Stock Evaluator: Veradigm Inc. (MDRX)

Veradigm Inc. MDRX

$4.90 -0.10 -2.00%
July 31, 2026 12:15:09 PM EST November 10, 2021 Volume: 25,950
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Technology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; clinical data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. Additionally, the company serves physician practices, hospitals, laboratory and radiology centers, urgent care facilities, health IT companies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Commentary & Analysis


Financial Summary

Share Statistics MDRX Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $545.0 $181.1 38%
Shares Out (Mil) 128.9 47.9 68%
Institutional Ownership 82.2% 78.5% 51%
Float (Mil) 52.1 40.1 48%
Beta 0.54 1.23 30%
Avg Daily Volume (000s) 16 205 19%
Price Change
(52-week)
(1.0%) 41.7% 45%
Growth MDRX Industry
Median
Percentile
(All Stocks)
Sales (5yr) (18.3%) 13.7% 3%
Net Income (5yr) (9.9%) (1.0%) 29%
EPS (5yr) (19.8%) 15.5% 13
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (38.2%) (15.5%) 12%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials MDRX Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $594 $192 44%
Net Income (TTM) (Mil) ($292) ($9) 5%
EPS (TTM) ($2.695) ($0.500) 12%
Operating Cash Flow (TTM) (Mil) ($20) $8 15%
Net Cash Flow (TTM) (Mil) $286 ($4) 87%
Long-Term Debt (Q1) (Mil) $213 $14 51%
Enterprise Value (Q1) (Mil) $282 $215 29%
Valuation MDRX Industry
Median
Percentile
(All Stocks)
P/B 0.46 1.17 8%
P/E na 35.7 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 2.0 na
Ratios MDRX Industry
Median
Percentile
(All Stocks)
Gross Margin 50.8% 61.6% 63%
Net Margin (49.0%) (29.3%) 12%
ROA (14.0%) (21.9%) 23%
ROE (22.5%) (1.4%) 23%
Liabilities to Assets 30.4% 33.3% 22%
F-Score 6 4 69%

Veradigm Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors